CoChat

Oxytocin inhibits lipopolysaccharide-induced inflammation in microglial cells and attenuates microglial activation in lipopolysaccharide-treated mice

Open access
Yuan, Lin, Liu, Song, Bai, Xuemei, Gao, Yan, Liu, Guangheng, Wang, Xueer, Liu, Dexiang, Li, Tong, Hao, Aijun, Wang, Zhen · 2016 · Journal of Neuroinflammation

The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Overactivated microglia is involved in various kinds of neurodegenerative diseases. Suppression of microglial overactivation has emerged as a novel strategy for treatment of neuroinflammation-based neurodegeneration. In the current study, anti-inflammatory effects of oxytocin (OT), which is a highly conserved nonapeptide with hormone and neurotransmitter properties, were investigated in vitro and in vivo. METHODS: BV-2 cells and primary microglia were pre-treated with OT (0.1, 1, and 10 μM) for 2 h followed by LPS treatment (500 ng/ml); microglial activation and pro-inflammatory mediators were measured by Western blot, RT-PCR, and immunofluorescence. The MAPK and NF-κB pathway proteins were assessed by Western blot. The intracellular calcium concentration ([Ca(2+)]i) was determined using Fluo2-/AM assay. Intranasal application of OT was pre-treated in BALB/C mice (adult male) followed by injected intraperitoneally with LPS (5 mg/kg). The effect of OT on LPS-induced microglial activation and pro-inflammatory mediators was measured by Western blot, RT-PCR, and immunofluorescence in vivo. RESULTS: Using the BV-2 microglial cell line and primary microglia, we found that OT pre-treatment significantly inhibited LPS-induced microglial activation and reduced subsequent release of pro-inflammatory factors. In addition, OT inhibited phosphorylation of ERK and p38 but not JNK MAPK in LPS-induced microglia. OT remarkably reduced the elevation of [Ca(2+)]i in LPS-stimulated BV-2 cells. Furthermore, a systemic LPS-treated acute inflammation murine brain model was used to study the suppressive effects of OT against neuroinflammation in vivo. We found that pre-treatment with OT showed marked attenuation of microglial activation and pro-inflammatory factor levels. CONCLUSIONS: Taken together, the present study demonstrated that OT possesses anti-neuroinflammatory activity and might serve as a potential therapeutic agent for treating neuroinflammatory diseases.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12974-016-0541-7

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Oxytocin receptor (OTR) expression in BV-2 cells and primary microglia. a Immunostaining with anti-OTR (red) in BV-2 cells and primary microglia. Nuclei were counterstained with DAPI (blue). Scale bar = 50 μm. b OTR mRNA expression in BV-2 cells after LPS challenged were analyzed by RT-PCR, β-actin was used to evaluate loading. c OTR protein expression in BV-2 cells after LPS challenged was analyzed by Western blotting, and β-actin was used to evaluate protein loading. d OTR mRNA expression in primary microglia after LPS challenged were analyzed by RT-PCR, β-actin was used to evaluate loading. e OTR protein expression in primary microglia after LPS challenged was analyzed by Western blotting, and β-actin was used to evaluate protein loading
Fig. 1 Oxytocin receptor (OTR) expression in BV-2 cells and primary microglia. a Immunostaining with anti-OTR (red) in BV-2 cells and primary microglia. Nuclei were counterstained with DAPI (blue). Scale bar = 50 μm. b OTR mRNA expression in BV-2 cells after LPS challenged were analyzed by RT-PCR, β-actin was used to evaluate loading. c OTR protein expression in BV-2 cells after LPS challenged was analyzed by Western blotting, and β-actin was used to evaluate protein loading. d OTR mRNA expression in primary microglia after LPS challenged were analyzed by RT-PCR, β-actin was used to evaluate loading. e OTR protein expression in primary microglia after LPS challenged was analyzed by Western blotting, and β-actin was used to evaluate protein loadingCC BY · PubMed Central
Fig. 2 Effects of OT pre-treatment on LPS-induced morphological changes in BV-2 cells and primary microglia. Morphological changes of BV-2 cells and primary microglia per-treated with or without OT (1 μM) for 2 h followed by LPS (500 ng/ml) for 24 h. Note the change in external morphology of microglia bearing long extending and stout processes after LPS insult. Scale bar = 50 μm
Fig. 2 Effects of OT pre-treatment on LPS-induced morphological changes in BV-2 cells and primary microglia. Morphological changes of BV-2 cells and primary microglia per-treated with or without OT (1 μM) for 2 h followed by LPS (500 ng/ml) for 24 h. Note the change in external morphology of microglia bearing long extending and stout processes after LPS insult. Scale bar = 50 μmCC BY · PubMed Central
Fig. 3 Effects of OT pre-treatment on LPS-induced microglial activation. a BV-2 cells and primary microglia were pre-treated with or without OT (1 μM) for 2 h followed by LPS (500 ng/ml) for 24 h, then stained with anti-Iba-1 (red), and counterstained with DAPI (blue). Quantification of the Iba-1 in BV-2 (b) and primary microglia (c) was determined by Image-Pro Plus 6.0. Scale bar = 50 μm. Images are representative of triplicate sets. Values were expressed relative to the fluorescence signal of respective controls. Values represent the mean ± S.D. **p < 0.01, ***p < 0.001 LPS VS Con; #p < 0.05, ##p < 0.01 LPS+ OT VS LPS
Fig. 3 Effects of OT pre-treatment on LPS-induced microglial activation. a BV-2 cells and primary microglia were pre-treated with or without OT (1 μM) for 2 h followed by LPS (500 ng/ml) for 24 h, then stained with anti-Iba-1 (red), and counterstained with DAPI (blue). Quantification of the Iba-1 in BV-2 (b) and primary microglia (c) was determined by Image-Pro Plus 6.0. Scale bar = 50 μm. Images are representative of triplicate sets. Values were expressed relative to the fluorescence signal of respective controls. Values represent the mean ± S.D. **p < 0.01, ***p < 0.001 LPS VS Con; #p < 0.05, ##p < 0.01 LPS+ OT VS LPSCC BY · PubMed Central
Fig. 4 Effects of OT on LPS-induced pro-inflammatory cytokine mRNA expression and secretion in microglia. a BV-2 cells were pre-treated with or without OT (0.1–10 μM) for 2 h followed by LPS (500 ng/ml) for 24 h. The levels of pro-inflammatory cytokines were analyzed by Western blotting, and β-actin was used to evaluate protein loading. b BV-2 cells were pre-treated with or without OT (0.1–10 μM) for 2 h followed by LPS (500 ng/ml) for 4 h. The relative expression levels of TNF-α and IL-1β gene were analyzed by RT-PCR. c Primary microglia were pre-treated with or without OT (1 μM) for 2 h followed by LPS (500 ng/ml) for 24 h. The levels of TNF-α and IL-1β were analyzed by Western blotting, and β-actin was used to evaluate protein loading. d Primary microglia were per-treated with or without OT (1 μM) for 2 h followed by LPS (500 ng/ml) for 24 h. The levels of TNF-α and IL-1β mRNA were analyzed by RT-PCR, and β-actin was used to evaluate protein loading. Each value was normalized to β-actin. Values represent the mean ± S.D. of three independent experiments. *p < 0.05, *** p < 0.001 LPS VS Con; #p < 0.05, ##p < 0.01, ###p < 0.001, LPS + OT VS LPS
Fig. 4 Effects of OT on LPS-induced pro-inflammatory cytokine mRNA expression and secretion in microglia. a BV-2 cells were pre-treated with or without OT (0.1–10 μM) for 2 h followed by LPS (500 ng/ml) for 24 h. The levels of pro-inflammatory cytokines were analyzed by Western blotting, and β-actin was used to evaluate protein loading. b BV-2 cells were pre-treated with or without OT (0.1–10 μM) for 2 h followed by LPS (500 ng/ml) for 4 h. The relative expression levels of TNF-α and IL-1β gene were analyzed by RT-PCR. c Primary microglia were pre-treated with or without OT (1 μM) for 2 h followed by LPS (500 ng/ml) for 24 h. The levels of TNF-α and IL-1β were analyzed by Western blotting, and β-actin was used to evaluate protein loading. d Primary microglia were per-treated with or without OT (1 μM) for 2 h followed by LPS (500 ng/ml) for 24 h. The levels of TNF-α and IL-1β mRNA were analyzed by RT-PCR, and β-actin was used to evaluate protein loading. Each value was normalized to β-actin. Values represent the mean ± S.D. of three independent experiments. *p < 0.05, *** p < 0.001 LPS VS Con; #p < 0.05, ##p < 0.01, ###p < 0.001, LPS + OT VS LPSCC BY · PubMed Central
Fig. 5 Effects of OT on LPS-induced COX-2 and iNOS mRNA and protein expression in microglia. a BV-2 cells were pre-treated with or without OT (0.1–10 μM) for 2 h followed by LPS (500 ng/ml) for 24 h. The levels of COX-2 and iNOS were analyzed by Western blotting, and β-actin was used to evaluate protein loading. b BV-2 cells were pre-treated with or without OT (0.1–10 μM) for 2 h followed by LPS (500 ng/ml) for 4 h. The relative expression levels of COX-2 and iNOS gene were analyzed by RT-PCR. c Primary microglia were pre-treated with or without OT (1 μM) for 2 h followed by LPS (500 ng/ml) for 24 h. The levels of COX-2 and iNOS were analyzed by Western blotting, and β-actin was used to evaluate protein loading. d Primary microglia were pre-treated with or without OT (1 μM) for 2 h followed by LPS (500 ng/ml) for 24 h. The levels of COX-2 and iNOS mRNA were analyzed by RT-PCR, and β-actin was used to evaluate protein loading. Each value was normalized to β-actin. Values represent the mean ± S.D. of three independent experiments. ***p < 0.001 LPS VS Con; #p < 0.05, ##p < 0.01, LPS+ OT VS LPS
Fig. 5 Effects of OT on LPS-induced COX-2 and iNOS mRNA and protein expression in microglia. a BV-2 cells were pre-treated with or without OT (0.1–10 μM) for 2 h followed by LPS (500 ng/ml) for 24 h. The levels of COX-2 and iNOS were analyzed by Western blotting, and β-actin was used to evaluate protein loading. b BV-2 cells were pre-treated with or without OT (0.1–10 μM) for 2 h followed by LPS (500 ng/ml) for 4 h. The relative expression levels of COX-2 and iNOS gene were analyzed by RT-PCR. c Primary microglia were pre-treated with or without OT (1 μM) for 2 h followed by LPS (500 ng/ml) for 24 h. The levels of COX-2 and iNOS were analyzed by Western blotting, and β-actin was used to evaluate protein loading. d Primary microglia were pre-treated with or without OT (1 μM) for 2 h followed by LPS (500 ng/ml) for 24 h. The levels of COX-2 and iNOS mRNA were analyzed by RT-PCR, and β-actin was used to evaluate protein loading. Each value was normalized to β-actin. Values represent the mean ± S.D. of three independent experiments. ***p < 0.001 LPS VS Con; #p < 0.05, ##p < 0.01, LPS+ OT VS LPSCC BY · PubMed Central
Fig. 6 OT reduces the increase in [Ca2+]i in LPS-stimulated BV-2 cells. a Representative 340/380 nm ratio of BV-2 cells showing the change of [Ca2+]i in BV-2 cells as induced by LPS (500 ng/ml) in the absence or presence of OT (1 μM). b Summary data (F/F0) of LPS-induced [Ca2+]i elevation, where F0 is the average baseline fluorescence before the application of LPS or OT, and F represents the fluorescence after the application of LPS or OT. n = 20 for LPS group; n = 20 for LPS and OT-co-treated group, ###p < 0.001 LPS + OT VS LPS. All data were shown as mean ± S.D.
Fig. 6 OT reduces the increase in [Ca2+]i in LPS-stimulated BV-2 cells. a Representative 340/380 nm ratio of BV-2 cells showing the change of [Ca2+]i in BV-2 cells as induced by LPS (500 ng/ml) in the absence or presence of OT (1 μM). b Summary data (F/F0) of LPS-induced [Ca2+]i elevation, where F0 is the average baseline fluorescence before the application of LPS or OT, and F represents the fluorescence after the application of LPS or OT. n = 20 for LPS group; n = 20 for LPS and OT-co-treated group, ###p < 0.001 LPS + OT VS LPS. All data were shown as mean ± S.D.CC BY · PubMed Central
Fig. 7 Effects of OT on LPS-induced phosphorylation of MAPK in BV-2 cells. BV-2 cells were pre-treated with or without OT (0.1–10 μM) for 2 h followed by LPS (500 ng/ml) for 60 min and total protein was subjected to Western blot analysis using antibodies against phospho-, or total forms of three MAPKs. Bar graphs showing quantification of expression levels of phosphor-MAPKs/MAPKs was determined by the Image-Pro Plus 6.0. Values represent the mean ± S.D. of four independent experiments. **p < 0.01 LPS VS Con; #p < 0.05, ##p < 0.01 LPS + OT VS LPS
Fig. 7 Effects of OT on LPS-induced phosphorylation of MAPK in BV-2 cells. BV-2 cells were pre-treated with or without OT (0.1–10 μM) for 2 h followed by LPS (500 ng/ml) for 60 min and total protein was subjected to Western blot analysis using antibodies against phospho-, or total forms of three MAPKs. Bar graphs showing quantification of expression levels of phosphor-MAPKs/MAPKs was determined by the Image-Pro Plus 6.0. Values represent the mean ± S.D. of four independent experiments. **p < 0.01 LPS VS Con; #p < 0.05, ##p < 0.01 LPS + OT VS LPSCC BY · PubMed Central
Fig. 8 Effects of OT on LPS-induced NF-κB activation in BV-2 cells. BV-2 cells were pre-treated with or without OT (0.1–10 μM) for 2 h followed by LPS (500 ng/ml) for 60 min and total protein was subjected to Western blot analysis using antibodies against IκB-α, phospho-, or total forms of NF-κB p65. Levels of β-actin were used to evaluate protein loading. Bar graphs showing quantification of expression levels of phosphor-NF-κB (p-NF-κB)/NF-κB were determined by the Image-Pro Plus 6.0. Values represent the mean ± S.D. of three independent experiments. ***p < 0.001 LPS VS Con
Fig. 8 Effects of OT on LPS-induced NF-κB activation in BV-2 cells. BV-2 cells were pre-treated with or without OT (0.1–10 μM) for 2 h followed by LPS (500 ng/ml) for 60 min and total protein was subjected to Western blot analysis using antibodies against IκB-α, phospho-, or total forms of NF-κB p65. Levels of β-actin were used to evaluate protein loading. Bar graphs showing quantification of expression levels of phosphor-NF-κB (p-NF-κB)/NF-κB were determined by the Image-Pro Plus 6.0. Values represent the mean ± S.D. of three independent experiments. ***p < 0.001 LPS VS ConCC BY · PubMed Central
Fig. 9 OT pre-treatment is associated with a decrease of microglial activation in vivo. Immunostaining with anti-Iba-1 (red) in the prefrontal cortex at 24 h after LPS treatment. Nuclei were counterstained with DAPI (blue). Scale bar = 50 μm. Values were expressed relative to the fluorescence signal of respective controls. Values represent the mean ± S.D., ***p < 0.01 LPS VS sham; ###p < 0.05 LPS + OT VS LPS
Fig. 9 OT pre-treatment is associated with a decrease of microglial activation in vivo. Immunostaining with anti-Iba-1 (red) in the prefrontal cortex at 24 h after LPS treatment. Nuclei were counterstained with DAPI (blue). Scale bar = 50 μm. Values were expressed relative to the fluorescence signal of respective controls. Values represent the mean ± S.D., ***p < 0.01 LPS VS sham; ###p < 0.05 LPS + OT VS LPSCC BY · PubMed Central
Fig. 10 (a) The levels of TNF-α and IL-1β production in the prefrontal cortex at 24 h after LPS injection were measured by western blotting, and β-actin was used to evaluate protein loading. Data were obtained from three separate experiments. (b) The relative expression levels of pro-inflammatory cytokines in the prefrontal cortex at 4 h after LPS injection were analyzed by RT-PCR. Each value was normalized to β-actin. Quantification of mRNA levels of the various cytokines as determined by Image-Pro Plus 6·0. Data were obtained from three separate experiments, Values represent the mean ± S.D., ** p < 0.01, *** p < 0.001 LPS VS Sham; # p < 0.05, ## p < 0.01 LPS+OT VS LPS
Fig. 10 (a) The levels of TNF-α and IL-1β production in the prefrontal cortex at 24 h after LPS injection were measured by western blotting, and β-actin was used to evaluate protein loading. Data were obtained from three separate experiments. (b) The relative expression levels of pro-inflammatory cytokines in the prefrontal cortex at 4 h after LPS injection were analyzed by RT-PCR. Each value was normalized to β-actin. Quantification of mRNA levels of the various cytokines as determined by Image-Pro Plus 6·0. Data were obtained from three separate experiments, Values represent the mean ± S.D., ** p < 0.01, *** p < 0.001 LPS VS Sham; # p < 0.05, ## p < 0.01 LPS+OT VS LPSCC BY · PubMed Central
Fig. 11 (a) Immunostaining with anti- Iba-1 (red) and TNF-α (green) in the prefrontal cortex at 24 h after LPS treatment. (b) Immunostaining with GFAP (red) and TNF-α (green) in the prefrontal cortex at 24 h after LPS treatment. Nuclei were counterstained with DAPI (blue). Scale bar = 50 μm. Values were expressed relative to the fluorescence signal of respective controls. Values represent the mean ± S.D., *** p < 0.001 LPS VS Sham; # p < 0.05 LPS+ OT VS LPS
Fig. 11 (a) Immunostaining with anti- Iba-1 (red) and TNF-α (green) in the prefrontal cortex at 24 h after LPS treatment. (b) Immunostaining with GFAP (red) and TNF-α (green) in the prefrontal cortex at 24 h after LPS treatment. Nuclei were counterstained with DAPI (blue). Scale bar = 50 μm. Values were expressed relative to the fluorescence signal of respective controls. Values represent the mean ± S.D., *** p < 0.001 LPS VS Sham; # p < 0.05 LPS+ OT VS LPSCC BY · PubMed Central
Fig. 12 (a) The expression of COX-2 and iNOS in the prefrontal cortex at 24 h after LPS injection were measured by western blotting, and β-actin was used to evaluate protein loading. Data were obtained from three separate experiments. (b) The relative expression levels of COX-2 and iNOS in the prefrontal cortex at 4 h after LPS injection were analyzed by RT-PCR. Each value was normalized to β-actin. Quantification of mRNA levels of the various cytokines as determined by Image-Pro Plus 6·0. Data were obtained from three separate experiments, Values represent the mean ± S.D., ** p < 0.01, *** p < 0.001 LPS VS Sham; # p < 0.05, ## p < 0.01 LPS+OT VS LPS
Fig. 12 (a) The expression of COX-2 and iNOS in the prefrontal cortex at 24 h after LPS injection were measured by western blotting, and β-actin was used to evaluate protein loading. Data were obtained from three separate experiments. (b) The relative expression levels of COX-2 and iNOS in the prefrontal cortex at 4 h after LPS injection were analyzed by RT-PCR. Each value was normalized to β-actin. Quantification of mRNA levels of the various cytokines as determined by Image-Pro Plus 6·0. Data were obtained from three separate experiments, Values represent the mean ± S.D., ** p < 0.01, *** p < 0.001 LPS VS Sham; # p < 0.05, ## p < 0.01 LPS+OT VS LPSCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 53 references

Cited by

See all 227

Metadata

Authors
Yuan, L., Liu, S., Bai, X., Gao, Y., Liu, G., Wang, X., Liu, D., Li, T., Hao, A., & Wang, Z.
Affiliations
Shandong University (CN)
Corresponding author
Wang, Zhen
Venue
Journal of Neuroinflammation
Published
2016-04-13
Volume
13
Issue
1
Pages
77-77
ISSN
1742-2094 (ISSN-L)
OpenAlex
W2336708411
Cited by
213
References
52
Citations by year
2026: 16 · 2025: 22 · 2024: 23 · 2023: 30 · 2022: 21 · 2021: 18 · 2020: 23 · 2019: 20 · 2018: 14 · 2017: 19 · 2016: 7
FWCI
10.96
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Journal of Neuroinflammation (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • Fundamental Research Funds of Shandong University (2015JC008)
  • National Natural Science Foundation of China (81200879)
Topics
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Neuroendocrine regulation and behavior
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
Keywords
oxytocin, microglial activation, neuroinflammation, lipopolysaccharide, anti-inflammatory activity, MAPK signaling, ERK, p38 MAPK, NF-κB, intracellular calcium, pro-inflammatory mediators, neurodegenerative diseases, intranasal administration
MeSH terms
Animals, Anti-Inflammatory Agents, Brain, Fluorescent Antibody Technique, Inflammation, Lipopolysaccharides, Mice, Inbred BALB C, Oxytocin, Blotting, Western, Microglia, Reverse Transcriptase Polymerase Chain Reaction, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Oxytocin inhibits lipopolysaccharide-induced inflammation in microglial cells and attenuates microglial activation in lipopolysaccharide-treated mice. https://app.cochat.ai/papers/10.1186/s12974-016-0541-7
The paper
Yuan, L., Liu, S., Bai, X., Gao, Y., Liu, G., Wang, X., Liu, D., Li, T., Hao, A., & Wang, Z. (2016). Oxytocin inhibits lipopolysaccharide-induced inflammation in microglial cells and attenuates microglial activation in lipopolysaccharide-treated mice. Journal of Neuroinflammation. https://doi.org/10.1186/s12974-016-0541-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.